Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Results from GOBACK: Non-chromosomal birth defects linked with cancer

AACR 2018

14 - 18 Apr 2018

Published: 25 Apr 2018

Views: 4540

Rating:

Save

Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA

Dr Schraw presents at AACR 2018 about the increased risk of children with non-chromosomal birth defects developing one of a host of childhood cancers.

Based on data from 4 US states between 1992-2013, researchers identified links between a range of birth defects and an increased risk of specific cancers.

Dr Schraw spoke with ecancer about these findings here.

Related Videos

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer

Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer ( Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia )

The added value of integrative medicine

Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos

The added value of integrative medicine ( Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos )

Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer

Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany

Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer ( Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany )

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems

Dr Bruce Montgomery - University of Washington, Seattle, USA

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems ( Dr Bruce Montgomery - University of Washington, Seattle, USA )

The genomics of cancer in Africa

Prof Solomon Rotimi - Covenant University, Ota, Nigeria

The genomics of cancer in Africa ( Prof Solomon Rotimi - Covenant University, Ota, Nigeria )

Genomic testing: Awareness and effective communication between healthcare professionals and patients

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens

Dr Krina Patel - MD Anderson Cancer Center, Houston, USA

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens ( Dr Krina Patel - MD Anderson Cancer Center, Houston, USA )

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer

Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

More from ecancer